NCPA kicks off new TV ad: "PBM Career Day"The new ad is part of NCPA's campaign to push lawmakers to enact pharmacy benefit manager reform. Upsher-Smith receives 2024 ASAP Alliance Excellence Award Upsher-Smith was recognized in the Alliance Program Excellence category. Watch DSN: Walgreens expands role in clinical trials for greater healthcare access DSN senior reporter Sandra Levy visited Perth Amboy, N.J., to discuss the new initiative with the retailer's clinical trials team. Sponsored The 2024 Smarter Purchasing Report: Uncover 5 Key Purchasing Trends Each year, SureCost conducts extensive customer analysis and compiles the anonymized information as a resource for pharmacies. Viatris completes divestitures with closing of OTC business divestiture The completion of the OTC divestiture is a major milestone in the execution of the company's strategic plan. Alembic gets FDA tentative OK for generic Bosulif Bosutinib tablets are indicated for the treatment of Philadelphia chromosome-positive chronic myelogenous leukemia. Dr Reddy's, Zydus Lifesciences to co-market Pertuzumab biosimilar in India Zydus will market the product under the brand name Sigrima, while Dr. Reddy's will market it as Womab. FDA gives Alembic tentative approval for generic Tibsovo Ivosidenib Tablets, 250, mg have a market value of roughly $114 million for the 12 months ending March 2024, per IQVIA. Sandoz obtains FDA nod for Stelara biosimilar Pyzchiva is used to treat a range of conditions. Amneal expands biosimilar portfolio with omalizumab Omalizumab is used to treat a number of chronic conditions such as severe persistent allergic asthma. First Previous 61 62 63 64 65 Next Last
